ASML stock slips in premarket after Aletheia upgrade lifts target to $1,500

ASML stock slips in premarket after Aletheia upgrade lifts target to $1,500

NEW YORK, January 2, 2026, 05:46 ET — Premarket

  • ASML shares were slightly lower in U.S. premarket trade after an analyst upgrade.
  • Investors are weighing China-related chip-tool rules and ASML’s late-January results for fresh 2026 signals.

ASML Holding N.V. (ASML) shares slipped 0.25% in U.S. premarket trading on Friday to $1,069.86. Aletheia Capital analyst Warren Lau double upgraded the Dutch chipmaking-equipment maker to Buy from Sell and raised his price target, an analyst estimate of where a stock should trade, to $1,500 from $750, TheFly reported. Lau told investors in a research note that “stronger extreme ultraviolet lithography demand from DRAM suppliers” would lift forecasts; extreme ultraviolet lithography is used to print the smallest chip features, and DRAM is a common type of memory chip. Tipranks

The call lands on the first full trading day of 2026, when investors are trying to gauge whether chipmakers are widening capital spending beyond last year’s artificial intelligence-driven demand.

ASML sits at the center of that debate because its tools are required to make the most advanced chips. Small shifts in expected orders can ripple through forecasts quickly, especially when companies time multi-billion-dollar equipment purchases.

Deep ultraviolet lithography is an older, widely used technology that prints less advanced layers and many “mature” chips, while extreme ultraviolet lithography is critical for the most advanced manufacturing steps. Demand for both matters for ASML because customers often buy multiple tool types across a new production buildout.

Policy risk around China remains a swing factor for chip-tool demand. This week the United States granted Taiwan Semiconductor Manufacturing Co an annual license to import U.S. chipmaking equipment into its Nanjing facility in China, replacing expiring exemptions and moving some shipments to a yearly approval process, TSMC said. Reuters

Chip stocks were mixed in early trading, underscoring how selective the market can be at the open of a new year. TSMC’s U.S.-listed shares rose 1.4% in premarket trade, while Nvidia fell 0.5%.

In Europe, equities started 2026 on a firm footing, with the STOXX 600 up 0.6% early Friday as investors returned from the holiday break, a Reuters market report said. Reuters

Macro events are also on traders’ radar as markets look for clues on the path for interest rates and risk-taking. The early-January calendar includes the U.S. payrolls report on Jan. 9, while investors are also watching for developments tied to tariffs and Federal Reserve leadership, Reuters reported. Reuters

ASML’s next earnings report is expected on Jan. 28 before U.S. markets open, according to Nasdaq’s earnings calendar. Nasdaq

Investors typically focus on ASML’s net bookings — a measure of orders received — because it offers a real-time read on chipmakers’ spending plans. Commentary on China demand, customer buildout schedules and margins can also move the stock.

ASML said in its most recent quarterly results release that it would provide more detail on its 2026 outlook in January. Asml

Lau’s $1,500 target sits about 40% above ASML’s latest premarket level. Price targets can shift sentiment quickly in thin early trading, but investors often wait for the company’s own order and guidance commentary before making bigger calls.

Stock Market Today

  • Kforce (KFRC) Q3 2025 Beat; valuation hints at potential turnaround
    January 2, 2026, 8:05 AM EST. Kforce Inc. (KFRC) beat the Zacks Consensus (analysts' average estimate tracked by Zacks Investment Research) in the third quarter of 2025, reporting EPS of $0.63 vs $0.57 expected, marking the first earnings surprise after two misses. Revenue fell 5.9% year over year to $332.6 million and declined 0.5% sequentially. Management said momentum carried into Q4, with better results in Technology and Finance & Accounting segments. The company's earnings outlook improved: the Zacks Consensus now projects $2.13 for 2025 and $2.28 for 2026. Valuation remains modest: forward P/E around 14.7x and P/S near 0.4x. The board expanded the buyback to $100 million and the annual dividend is $1.56 per share, yielding about 5%. Still, the stock trades near a five-year low in 2025, underscoring a bruise to sentiment amid a tougher staffing backdrop.
HSBC stock today: London shares hit a fresh high as FTSE 100 tops 10,000; U.S. ADRs steady premarket
Previous Story

HSBC stock today: London shares hit a fresh high as FTSE 100 tops 10,000; U.S. ADRs steady premarket

Novo Nordisk stock slips premarket as China court backs key semaglutide patent
Next Story

Novo Nordisk stock slips premarket as China court backs key semaglutide patent

Go toTop